Aerovate Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $10k | 4.9k | 2.09 |
| 2024-06-30 | $8.4k | 5.1k | 1.66 |
| 2024-03-31 | $99k | 3.4k | 29.57 |
| 2023-12-31 | $66k | 2.9k | 22.63 |
| 2023-09-30 | $31k | 2.3k | 13.57 |
| 2023-06-30 | $72k | 4.2k | 17.15 |
| 2022-09-30 | $0 | 28 | 0.00 |
| 2022-06-30 | $2.0k | 118 | 16.95 |
| 2022-03-31 | $27k | 1.5k | 18.04 |
| 2021-12-31 | $52k | 4.5k | 11.69 |
| 2021-09-30 | $999 | 55 | 18.18 |